Advisors Asset Management Inc. Acquires 16,661 Shares of Colgate-Palmolive (NYSE:CL)

Advisors Asset Management Inc. grew its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 35.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 64,264 shares of the company's stock after purchasing an additional 16,661 shares during the period. Advisors Asset Management Inc.'s holdings in Colgate-Palmolive were worth $6,671,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CL. Gordian Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $602,000. Carrera Capital Advisors increased its position in Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company's stock worth $4,066,000 after buying an additional 7,353 shares during the period. Vontobel Holding Ltd. grew its position in shares of Colgate-Palmolive by 224.6% during the 3rd quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company's stock worth $82,626,000 after purchasing an additional 550,750 shares in the last quarter. PGGM Investments raised its position in shares of Colgate-Palmolive by 171.8% in the 2nd quarter. PGGM Investments now owns 157,608 shares of the company's stock valued at $15,294,000 after buying an additional 99,624 shares in the last quarter. Finally, QRG Capital Management Inc. lifted its stake in Colgate-Palmolive by 11.2% in the 2nd quarter. QRG Capital Management Inc. now owns 57,275 shares of the company's stock valued at $5,558,000 after purchasing an additional 5,751 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Up 0.1 %

Shares of NYSE CL traded up $0.06 during midday trading on Thursday, reaching $93.97. 374,928 shares of the company's stock were exchanged, compared to its average volume of 4,372,522. Colgate-Palmolive has a 52-week low of $75.50 and a 52-week high of $109.30. The stock has a market capitalization of $76.77 billion, a PE ratio of 26.91, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The business's fifty day moving average price is $98.56 and its two-hundred day moving average price is $98.52.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.13%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.

Analysts Set New Price Targets

CL has been the subject of several analyst reports. Sanford C. Bernstein raised their price target on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a research note on Tuesday, July 30th. HSBC restated a "hold" rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. UBS Group lifted their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their target price for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. Finally, Redburn Atlantic upgraded Colgate-Palmolive to a "hold" rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Insider Transactions at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the firm's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares of the company's stock, valued at approximately $1,220,874.30. The trade was a 16.44 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.34% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.